ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ERGO Ergomed Plc

1,346.00
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,346.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ergomed plc Cancellation of admission to trading of shares (2856T)

14/11/2023 7:30am

UK Regulatory


Ergomed (LSE:ERGO)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Ergomed Charts.

TIDMERGO

RNS Number : 2856T

Ergomed plc

14 November 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

For immediate release

14 November 2023

Ergomed plc

Cancellation of admission to trading of Ergomed Shares

Further to the announcement on 13 November 2023 that the Scheme for the acquisition of the entire issued and to be issued ordinary share capital of Ergomed plc ("Ergomed" or the "Company") by Eden AcquisitionCo Limited has now become Effective in accordance with its terms, Ergomed confirms that AIM has cancelled the admission to trading of Ergomed Shares on AIM with effect from 7.00 a.m. today, 14 November 2023.

Defined terms used but not defined in this announcement have the meanings set out in the Scheme Document dated 22 September 2023. All references to times in this announcement are to London time.

Enquiries:

Ergomed +44 (0) 1483 307 920

Miroslav Reljanović (Executive Chairman)

Jonathan Curtain (Chief Financial Officer)

Keith Byrne (Senior Vice President, Capital Markets and Strategy)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZMMMVFZGFZM

(END) Dow Jones Newswires

November 14, 2023 02:30 ET (07:30 GMT)

1 Year Ergomed Chart

1 Year Ergomed Chart

1 Month Ergomed Chart

1 Month Ergomed Chart

Your Recent History

Delayed Upgrade Clock